Cladis Investment Advisory, LLC Sio Gene Therapies Inc. Transaction History

Cladis Investment Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.4 - $0.46 $28,000 - $32,200	-70,000 Reduced 46.67%	80,000 $32,000
Q4 2022 Feb 14, 2023	SELL	$0.28 - $0.44 $112,560 - $176,880	-402,000 Reduced 72.83%	150,000 $65,000
Q3 2022 Nov 17, 2022	SELL	$0.28 - $0.41 $51,800 - $75,850	-185,000 Reduced 25.1%	552,000 $155,000
Q2 2022 Aug 09, 2022	SELL	$0.25 - $0.73 $97,250 - $283,970	-389,000 Reduced 34.55%	737,000 $265,000
Q1 2022 May 10, 2022	BUY	$0.55 - $1.47 $12,100 - $32,340	22,000 Added 1.99%	1,126,000 $754,000
Q4 2021 Oct 01, 2024	BUY	$1.29 - $2.36 $1.55 Million - $2.84 Million	1,204,000 New	1,204,000 $1.42 Billion
Q4 2021 May 10, 2022	BUY	$1.29 - $2.36 $1.42 Million - $2.61 Million	1,104,000 New	1,104,000 $1.42 Million

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cladis Investment Advisory, LLC with notifications on news.